GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,620,000 | +1.8% | 37,192 | +3.0% | 0.01% | +20.0% |
| Q4 2021 | $1,592,000 | +23.0% | 36,098 | +6.6% | 0.01% | +25.0% |
| Q3 2021 | $1,294,000 | -42.8% | 33,864 | -40.4% | 0.00% | -50.0% |
| Q2 2021 | $2,261,000 | -59.7% | 56,779 | -63.9% | 0.01% | -61.9% |
| Q1 2021 | $5,614,000 | -8.7% | 157,299 | -5.8% | 0.02% | -8.7% |
| Q4 2020 | $6,147,000 | -1.2% | 167,051 | +1.1% | 0.02% | -11.5% |
| Q3 2020 | $6,222,000 | +11.7% | 165,314 | +21.1% | 0.03% | -3.7% |
| Q2 2020 | $5,569,000 | +18.6% | 136,530 | +10.1% | 0.03% | -6.9% |
| Q1 2020 | $4,697,000 | -24.4% | 123,955 | -6.2% | 0.03% | -9.4% |
| Q4 2019 | $6,210,000 | +5.7% | 132,155 | -4.0% | 0.03% | -5.9% |
| Q3 2019 | $5,873,000 | -4.3% | 137,615 | -10.2% | 0.03% | -2.9% |
| Q2 2019 | $6,135,000 | -3.9% | 153,296 | +0.3% | 0.04% | -10.3% |
| Q1 2019 | $6,385,000 | +14.7% | 152,785 | +4.9% | 0.04% | -4.9% |
| Q4 2018 | $5,568,000 | +18.2% | 145,710 | +24.2% | 0.04% | +41.4% |
| Q3 2018 | $4,711,000 | +15.0% | 117,277 | +15.4% | 0.03% | +3.6% |
| Q2 2018 | $4,098,000 | +4.6% | 101,662 | +1.4% | 0.03% | 0.0% |
| Q1 2018 | $3,916,000 | +29.6% | 100,229 | +17.6% | 0.03% | +33.3% |
| Q4 2017 | $3,022,000 | -63.0% | 85,204 | -57.6% | 0.02% | -65.6% |
| Q3 2017 | $8,157,000 | -27.6% | 200,918 | -23.2% | 0.06% | -28.2% |
| Q2 2017 | $11,274,000 | +20.7% | 261,464 | +17.9% | 0.08% | +13.3% |
| Q1 2017 | $9,340,000 | +81.8% | 221,812 | +66.3% | 0.08% | +63.0% |
| Q4 2016 | $5,137,000 | -21.0% | 133,387 | -11.5% | 0.05% | -19.3% |
| Q3 2016 | $6,502,000 | +179.7% | 150,760 | +181.0% | 0.06% | +159.1% |
| Q2 2016 | $2,325,000 | +33.2% | 53,644 | +24.5% | 0.02% | +37.5% |
| Q1 2016 | $1,746,000 | -25.6% | 43,082 | -26.0% | 0.02% | -27.3% |
| Q4 2015 | $2,348,000 | +3.5% | 58,203 | -1.3% | 0.02% | +10.0% |
| Q3 2015 | $2,268,000 | -10.5% | 58,997 | -3.0% | 0.02% | +400.0% |
| Q2 2015 | $2,534,000 | -9.7% | 60,853 | +0.1% | 0.00% | 0.0% |
| Q1 2015 | $2,807,000 | +40.4% | 60,822 | +30.0% | 0.00% | +33.3% |
| Q4 2014 | $1,999,000 | -1.8% | 46,778 | +5.6% | 0.00% | 0.0% |
| Q3 2014 | $2,035,000 | -22.7% | 44,293 | -10.1% | 0.00% | -25.0% |
| Q2 2014 | $2,633,000 | +2.3% | 49,246 | +2.2% | 0.00% | 0.0% |
| Q1 2014 | $2,573,000 | +6.2% | 48,171 | +6.2% | 0.00% | 0.0% |
| Q4 2013 | $2,422,000 | -44.7% | 45,365 | -48.0% | 0.00% | -50.0% |
| Q3 2013 | $4,378,000 | +3.5% | 87,287 | +3.1% | 0.01% | 0.0% |
| Q2 2013 | $4,230,000 | – | 84,654 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |